STAT3 and metabolic dysfunction-associated steatotic liver disease: Moreover, short-term CM stimulation revealed that blockade of CCR5 signaling enhanced g-MDSCs’ STAT3 activation in a healthy liver environment but did not alter STAT3 activity in the NAFLD microenvironment (Figure 4f).